NEWTON, Mass.--(BUSINESS WIRE)--May 2, 2006--Matritech (Amex: MZT - News), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the first quarter ended March 31, 2006. The company also reaffirmed its full year guidance of $14-15 million in product revenues.
